Feed Preview

Progressive Supranuclear Palsy

Progressive Supranuclear Palsy diagram by Laughlin Dawes, Wikimedia
Laughlin Dawes, Wikimedia

Progressive Supranuclear Palsy (PSP) is a rare neurodegenerative disorder that affects movement, gait, balance, and speech. Discover the latest research on PSP here.

Top 20 most recent papers
Journal of Movement Disorders

The Non-Motor Symptom Profile of Progressive Supranuclear Palsy

Journal of Movement DisordersApril 4, 2020
Sudhakar Pushpa ChaithraPramod Kumar Pal
Neurology. Clinical Practice

Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants

Neurology. Clinical PracticeMarch 20, 2020
Christopher G TarolliJamie L Adams
5
1
1
Journal of Neuropathology and Experimental Neurology

Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD

Journal of Neuropathology and Experimental NeurologyJanuary 31, 2020
John L RobinsonJohn Q Trojanowski
2
1
Movement Disorders : Official Journal of the Movement Disorder Society

Automated MRI Classification in Progressive Supranuclear Palsy: a Large International Cohort Study

Movement Disorders : Official Journal of the Movement Disorder SocietyFebruary 25, 2020
Salvatore NigroAldo Quattrone
10
1
Advances in Experimental Medicine and Biology

Structure of NFT: Biochemical Approach

Advances in Experimental Medicine and BiologyFebruary 26, 2020
Masato Hasegawa
1
Neuroscience and Biobehavioral Reviews

Central auditory processing in Parkinsonian disorders: A systematic review

Neuroscience and Biobehavioral ReviewsMarch 8, 2020
Evelien De GrooteMiet De Letter
1
Movement Disorders : Official Journal of the Movement Disorder Society

Copathology in Progressive Supranuclear Palsy: Does It Matter?

Movement Disorders : Official Journal of the Movement Disorder SocietyMarch 4, 2020
Milica Jecmenica LukicGünter U Höglinger
19
2
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes

Contribution of the Mesencephalon Indices to Differential Diagnosis of Parkinsonian Disorders

Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des RadiologistesFebruary 18, 2020
Cemil OktayKamil Karaali
Movement Disorders : Official Journal of the Movement Disorder Society

Progressive Supranuclear Palsy and Statin Use

Movement Disorders : Official Journal of the Movement Disorder SocietyMarch 29, 2020
Ece Bayramand the ENGENE-PSP Consortium
5
1
Movement Disorders : Official Journal of the Movement Disorder Society

Association of Tripartite Motif Containing 11 rs564309 with Tau Pathology in Progressive Supranuclear Palsy

Movement Disorders : Official Journal of the Movement Disorder SocietyMarch 7, 2020
Rebecca R ValentinoOwen A Ross
2
Journal of Neuropathology and Experimental Neurology

Generation and Characterization of Novel Monoclonal Antibodies Targeting p62/sequestosome-1 Across Human Neurodegenerative Diseases

Journal of Neuropathology and Experimental NeurologyFebruary 28, 2020
Jorge A Trejo-LopezBenoit I Giasson
3
1
Acta Neuropathologica Communications

A single ultrasensitive assay for detection and discrimination of tau aggregates of Alzheimer and Pick diseases

Acta Neuropathologica CommunicationsFebruary 24, 2020
Michael A MetrickByron Caughey
1
1

See more papers from this feed

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/progressive-supranuclear-palsy/74d585e5-85bd-4f41-b8b5-ad129100b4a1